2024
DOI: 10.17998/jlc.2024.02.21
|View full text |Cite
|
Sign up to set email alerts
|

Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?

Bernardo Stefanini,
Luca Ielasi,
Dante Pio Pallotta
et al.

Abstract: This review explores the evolution of cancer staging, focusing on intermediate hepatocellular carcinoma (HCC), and the challenges faced by physicians. The Barcelona Clinic Liver Cancer (BCLC) staging system, introduced in 1999, was designed to address the limitations associated with providing accurate prognostic information for HCC and allocating specific treatments, to avoid overtreatment. However, criticism has emerged, particularly regarding the intermediate stage of HCC (BCLC-B) and its heterogeneous patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 74 publications
0
0
0
Order By: Relevance